KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 3.855
AS - Asia 1.630
EU - Europa 1.280
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 195
AF - Africa 106
OC - Oceania 2
Totale 7.449
Nazione #
US - Stati Uniti d'America 3.721
SG - Singapore 479
IT - Italia 358
RU - Federazione Russa 339
BR - Brasile 303
VN - Vietnam 301
CN - Cina 277
HK - Hong Kong 244
BD - Bangladesh 124
FR - Francia 113
IE - Irlanda 109
SE - Svezia 88
GB - Regno Unito 73
CA - Canada 56
IN - India 56
DE - Germania 44
CI - Costa d'Avorio 36
AR - Argentina 26
FI - Finlandia 24
MX - Messico 24
PL - Polonia 24
LT - Lituania 22
AT - Austria 20
NL - Olanda 20
ZA - Sudafrica 20
IQ - Iraq 16
TR - Turchia 15
ES - Italia 14
JP - Giappone 14
ID - Indonesia 13
EC - Ecuador 12
MA - Marocco 12
VE - Venezuela 12
PY - Paraguay 10
SV - El Salvador 10
PH - Filippine 9
PK - Pakistan 9
CO - Colombia 8
CR - Costa Rica 8
CW - ???statistics.table.value.countryCode.CW??? 7
KE - Kenya 7
SA - Arabia Saudita 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
HN - Honduras 6
IL - Israele 6
JM - Giamaica 6
UA - Ucraina 6
UZ - Uzbekistan 6
EG - Egitto 5
JO - Giordania 5
PR - Porto Rico 5
TN - Tunisia 5
CL - Cile 4
KR - Corea 4
MY - Malesia 4
NI - Nicaragua 4
NP - Nepal 4
TT - Trinidad e Tobago 4
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 7.250
Città #
Ashburn 755
Des Moines 380
San Jose 326
Singapore 312
Chandler 311
Hong Kong 238
Council Bluffs 179
Dallas 122
Dublin 108
Boardman 100
Ho Chi Minh City 88
Beijing 77
Hanoi 71
Fairfield 68
The Dalles 68
Los Angeles 63
Lauterbourg 60
New York 58
Moscow 44
Phoenix 43
Milan 42
Hefei 39
Abidjan 36
Ancona 36
Buffalo 36
Santa Clara 36
Princeton 32
Rome 31
Lawrence 30
San Mateo 28
São Paulo 28
Wilmington 28
Houston 27
Orem 27
Pune 25
Turin 24
Woodbridge 22
Helsinki 21
Seattle 21
Clovis 20
Warsaw 20
Chicago 19
Montreal 19
Nuremberg 19
Vilnius 19
Falls Church 18
Cambridge 16
Marche 16
Rio de Janeiro 15
Da Nang 14
San Francisco 14
Ann Arbor 13
Atlanta 12
Columbus 12
Frankfurt am Main 12
Shanghai 12
Tokyo 12
Vienna 12
Denver 11
Haiphong 11
Lynnwood 11
San Diego 11
Stockholm 11
Washington 11
Boston 10
Naples 10
London 9
Manchester 9
Toronto 9
Amsterdam 8
Brasília 8
Chennai 8
Ankara 7
Bologna 7
Brooklyn 7
Johannesburg 7
Mexico City 7
Miano 7
Norwalk 7
Willemstad 7
Bangkok 6
Dong Ket 6
Falconara Marittima 6
Guayaquil 6
Istanbul 6
Medellín 6
Miami 6
San José 6
San Salvador 6
Tashkent 6
Amman 5
Baghdad 5
Belton 5
Campinas 5
Goiânia 5
Guangzhou 5
Harper Woods 5
Hải Dương 5
Palermo 5
Portsmouth 5
Totale 4.637
Nome #
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 215
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 175
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 165
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 146
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 144
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 143
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 142
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 141
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 140
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 138
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues. Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 137
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 134
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 130
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 129
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 127
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 127
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 125
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 123
Cluster stability in the analysis of mass cytometry data 122
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 120
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 120
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 119
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 118
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 115
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 115
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 112
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 112
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 111
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 111
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 109
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 106
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 106
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 106
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 105
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 105
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 102
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 101
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy 100
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 96
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 96
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 94
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 94
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 94
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 89
Natural born survivors: The inglorious TP53 87
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 84
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 82
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 81
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 80
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 79
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 79
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 78
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 76
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 75
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 75
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 74
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 73
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 71
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 71
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 70
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 69
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 67
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 65
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 64
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 63
Functional characterization of CD4+ T cells in aplastic anemia 63
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 62
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 62
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 62
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 59
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 57
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 52
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia 33
High frequency of CD95+/CD45RA− regulatory T cells defines an immunosuppressive profile associated with MDS progression 28
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM‐prognostic score (FCM‐PS) for overall survival 17
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group 13
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology 11
Navigating recurrent immune-mediated thrombotic thrombocytopenic purpura (iTTP) in pregnancy: A case report and literature review 8
Totale 7.449
Categoria #
all - tutte 36.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 0 0 0 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/20251.241 75 117 46 18 47 73 202 64 254 74 111 160
2025/20263.402 170 169 174 207 322 236 654 328 345 351 236 210
2026/2027902 184 121 170 402 25 0 0 0 0 0 0 0
Totale 7.449